MedTrace Logo

Evaluation of Deposits on Contact Lenses Worn Extended Wear

NCT00725530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2012-08-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to measure lipid deposits on commercially marketed contact lenses when worn on an extended wear (overnight) basis for 7 days.

Conditions

  • Myopia

Interventions

DEVICE

balafilcon A contact lens (PureVision)

Commercially marketed, silicone hydrogel contact lens

DEVICE

etafilcon A contact lens (Acuvue2)

Commercially marketed, hydrogel contact lens

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00725530 on ClinicalTrials.gov